Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPT
2326
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.83M | ﹤0.01% |
135,000
+90,400
| +203% | +$1.11M |
|
|
TGNA
2327
DELISTED
TEGNA Inc
TGNA
| $1.83M | ﹤0.01% |
117,670
-1,601,930
| -93% | -$24.2M |
|
2328
iShares MSCI Taiwan ETF
EWT
$11.5B
| $1.82M | ﹤0.01% |
+50,200
| New | +$1.77M |
|
2329
Moog Inc Class A
MOG.A
$14B
| $1.82M | ﹤0.01% |
22,500
-27,400
| -55% | -$2.33M |
|
|
HT
2330
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.82M | ﹤0.01% |
122,561
+109,961
| +873% | +$1.68M |
|
2331
Jakks Pacific
JAKK
$294M
| $1.82M | ﹤0.01% |
212,948
-60
| -0% | -$486 |
|
2332
Park-Ohio Holdings
PKOH
$708M
| $1.81M | ﹤0.01% |
60,800
-31,893
| -34% | -$950K |
|
2333
Archrock
AROC
$6.05B
| $1.8M | ﹤0.01% |
180,900
-81,600
| -31% | -$814K |
|
2334
Coca-Cola Europacific Partners
CCEP
$47.5B
| $1.8M | ﹤0.01% |
32,325
+3,130
| +11% | +$175K |
|
2335
Ampco-Pittsburgh
AP
$195M
| $1.8M | ﹤0.01% |
489,024
+12,000
| +3% | +$45K |
|
2336
Amplify Energy
AMPY
$200M
| $1.8M | ﹤0.01% |
291,600
-453,685
| -61% | -$2.56M |
|
|
SIOX
2337
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.8M | ﹤0.01% |
278,023
-51,800
| -16% | -$357K |
|
|
GIFI
2338
DELISTED
Gulf Island Fabrication
GIFI
| $1.79M | ﹤0.01% |
335,229
+127,400
| +61% | +$835K |
|
2339
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
| $1.79M | ﹤0.01% |
20,400
-19,900
| -49% | -$1.7M |
|
2340
iShares TIPS Bond ETF
TIP
$14.7B
| $1.79M | ﹤0.01% |
+15,375
| New | +$1.78M |
|
2341
Gevo
GEVO
$420M
| $1.79M | ﹤0.01% |
533,394
+103,900
| +24% | +$283K |
|
2342
Standex International
SXI
$4.02B
| $1.79M | ﹤0.01% |
24,500
+21,500
| +717% | +$1.49M |
|
|
TRQ
2343
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $1.78M | ﹤0.01% |
+374,578
| New | +$2.25M |
|
2344
Fulgent Genetics
FLGT
$513M
| $1.77M | ﹤0.01% |
170,480
+138,414
| +432% | +$1.31M |
|
|
HTT
2345
High Templar Tech Ltd
HTT
$391M
| $1.77M | ﹤0.01% |
257,000
-1,760,900
| -87% | -$14.2M |
|
2346
Hallador Energy
HNRG
$762M
| $1.77M | ﹤0.01% |
488,458
+66,166
| +16% | +$313K |
|
|
MSBF
2347
DELISTED
MSB Financial Corp.
MSBF
| $1.77M | ﹤0.01% |
109,800
+5,794
| +6% | +$93K |
|
2348
InfuSystem Holdings
INFU
$244M
| $1.77M | ﹤0.01% |
333,953
+19,231
| +6% | +$93K |
|
2349
Interface
TILE
$2.19B
| $1.74M | ﹤0.01% |
120,506
+67,900
| +129% | +$888K |
|
2350
CB Financial Services
CBFV
$188M
| $1.74M | ﹤0.01% |
62,517
+3,917
| +7% | +$98.9K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.